The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/10723585

Download in:

View as

General Info

PMID
10723585